Plasma‐Treated Liquids for Medicine: A Narrative Review on State and Perspectives
Plasma Processes and Polymers · 2025-01 · 22 (1)
DOI: 10.1002/ppap.202400255 ↗Kurz gefasst
Fachartikel in der Zeitschrift Plasma Processes and Polymers, online erschienen am 17.12.2024. Verfasst von Thomas von Woedtke und 3 weiteren Autor:innen. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Plasma‐treated liquids and their medical application have gained momentum in the fields of plasma science in recent years. Most research has been done in the field of cancer treatment. Another new and promising special field of CAP−liquid interaction is hydrogels, which can serve as localized reservoirs for the delivery of long‐lived reactive oxygen and nitrogen species and other active ingredients such as chemotherapeutic drugs. Identifying liquids and hydrogel compositions optimal for plasma treatment, for their reservoir function, and from a regulatory point of view for use in medicine, together with the chemical identification of biologically active molecules and interdependencies to plasma operation parameters, are the fundamental challenges in the field.
Zitieren
APA
Woedtke, T. V., Bekeschus, S., Weltmann, K., & Wende, K. (2025). Plasma‐Treated Liquids for Medicine: A Narrative Review on State and Perspectives. Plasma Processes and Polymers, 22(1). https://doi.org/10.1002/ppap.202400255
Vancouver
Woedtke TV, Bekeschus S, Weltmann K, Wende K. Plasma‐Treated Liquids for Medicine: A Narrative Review on State and Perspectives. Plasma Processes and Polymers. 2025;22(1). doi:10.1002/ppap.202400255
BibTeX
@article{Woedtke2025,
author = {Woedtke, Thomas von and Bekeschus, Sander and Weltmann, Klaus‐Dieter and Wende, Kristian},
title = {Plasma‐Treated Liquids for Medicine: A Narrative Review on State and Perspectives},
journal = {Plasma Processes and Polymers},
year = {2025},
volume = {22},
number = {1},
doi = {10.1002/ppap.202400255}
}
EUVIMED